Investigational Drugs List
Groups Distribution
Phase Distribution
Filter Conditions
Investigational Drugs List
| Drugs ID | CID | Drugs | Identifier | Molecular Formula | Molecular Weight | Groups | US Approved | Details |
|---|---|---|---|---|---|---|---|---|
| Drug181 | 139082353 | Steroids | NCT05702879, NCT03460847 | C26H44N2O | 400.60 | NULL | NULL | Details |
| Drug182 | 139266768 | Ferric carboxymaltose | NCT02517151, NCT04587141, NCT00810030 | C24H44FeO25- | 788.40 | approved | YES | Details |
| Drug183 | 146170995 | Glepaglutide | NCT00868660 | C197H325N53O55 | 4316.00 | NULL | NULL | Details |
| Drug184 | 146273261 | GLPG3970 | NCT04577794 | C25H27F3N4O4 | 504.50 | NULL | NULL | Details |
| Drug185 | 146444831 | PF-07054894 | NCT05549323 | C24H30N6O4 | 466.50 | NULL | NULL | Details |
| Drug186 | 146651362 | MS-20 | NCT04908644 | C24H21N3O3 | 399.40 | NULL | NULL | Details |
| Drug187 | 155407072 | Tilpisertib Fosmecarbil | NCT06029972 | C35H36ClN8O7P | 747.10 | NULL | NO | Details |
| Drug188 | 168325625 | BL-7040 | NCT01506362 | C194H253N64O106P19S19 | 6375.00 | NULL | NULL | Details |
| Drug189 | 2756 | Cimetidine | NCT05020184, NCT05365451, NCT04862585, NCT06056583, NCT03307252, NCT03380455, NCT04493931, NCT01010698, NCT04018131, NCT03618316, NCT02157376, NCT01757275, NCT02555852, NCT02202512, NCT00515073, NCT02172417, NCT00002733, NCT00800280, NCT00002092 | C10H16N6S | 252.34 | approved | YES | Details |
| Drug190 | 5339 | Sulfasalazine | NCT03414502, NCT02714634, NCT03254589, NCT03739853, NCT03847311, NCT04720183, NCT06060301, NCT04725422, NCT02451748, NCT05580861, NCT05664464, NCT03561584, NCT05703425, NCT06360068, NCT06134388, NCT04205357, NCT05445440, NCT04610476, NCT02374021, NCT02466 | C18H14N4O5S | 398.40 | approved | YES | Details |